Saniona AB (publ) (STO:SANION)
11.79
-0.05 (-0.42%)
Sep 2, 2026, 5:29 PM CET
Saniona AB Market Cap
Saniona AB has a market cap or net worth of 1.63 billion as of September 2, 2026. Its market cap has decreased by -5.43% in one year.
Market Cap
1.63B
Enterprise Value
1.15B
Revenue
424.56M
Ranking
n/a
PE Ratio
9.07
Stock Price
11.79
ChartMarket Cap Chart
Since April 22, 2014, Saniona AB's market cap has increased from 71.49M to 1.63B, an increase of 2,185.92%. That is a compound annual growth rate of 28.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.63B | -44.15% |
| Dec 30, 2025 | 2.93B | 223.43% |
| Dec 30, 2024 | 904.76M | 251.84% |
| Dec 29, 2023 | 257.15M | 34.48% |
| Dec 30, 2022 | 191.21M | -65.37% |
| Dec 30, 2021 | 552.11M | -57.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 4.35B |
| Egetis Therapeutics AB | 3.67B |
| Vicore Pharma Holding AB | 3.01B |
| Flerie AB | 1.56B |
| BioInvent International AB | 1.52B |
| Genovis AB (publ.) | 1.44B |
| Medivir AB | 1.22B |
| SynAct Pharma AB | 1.15B |